Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target

Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and limited antigens (type I and II latencies) in immunocompetent patients. Post-transplantation lymphoproliferative disease (PTLD) is the prototype...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Eric, Kwong, Yok-Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314579/
https://www.ncbi.nlm.nih.gov/pubmed/25613733
http://dx.doi.org/10.1038/emm.2014.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314579/
https://www.ncbi.nlm.nih.gov/pubmed/25613733
http://dx.doi.org/10.1038/emm.2014.102

Ejemplares similares